Alzheimer's risk gene APOE4 shows reversible weaknesses in experiments
· Science
Researchers found that the APOE4 gene, a major Alzheimer's risk factor, may damage brain blood vessels and disrupt cellular systems that clear harmful proteins. In experiments they were able to reverse some of these effects, pointing to new therapeutic targets for Alzheimer's, Parkinson's and other neurodegenerative diseases.
Why it matters:If the reversal mechanism holds up in further studies, it could open a new class of treatments for neurodegenerative diseases that currently have no disease-modifying therapies.
Key points
- APOE4 is the strongest known genetic risk factor for late-onset Alzheimer's disease.
- The experiments also suggest implications for Parkinson's and other neurodegenerative conditions.
Sources (original reporting)
More stories from this day
- Endometriosis drug shows early promise for 190 million patients
- Caltech physicists observe quantum energy ladder predicted 40 years ago
- Superfluid helium qubit could cut quantum error rates 100-fold
- Hidden artery plaque found in 1 in 13 adults under 30
- Nvidia launches Open Agent Safety Platform to contain rogue AI agents
- France at Center of Global Bond Rout as Paris Plans Big Spending Cuts